Author: Lim, Jaegyun; Jeon, Seunghyun; Shin, Hyun-Young; Kim, Moon Jung; Seong, Yu Min; Lee, Wang Jun; Choe, Kang-Won; Kang, Yu Min; Lee, Baeckseung; Park, Sang-Joon
Title: Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR Document date: 2020_2_14
ID: t159ctrv_7
Snippet: There were some reports about lopinavir/ritonavir (Kaletra, AbbVie) for the treatment of COVID-19. 1 Lopinavir/ritonavir was started from the hospital day 8 (day 10 of illness); 2 tablets (lopinavir 200 mg/ritonavir 50 mg) were given per oral bid. Interestingly, from the next day of lopinavir/ritonavir administration, β-coronavirus viral load started to decrease and no detectable or little coronavirus titers have been observed since then ( Fig. .....
Document: There were some reports about lopinavir/ritonavir (Kaletra, AbbVie) for the treatment of COVID-19. 1 Lopinavir/ritonavir was started from the hospital day 8 (day 10 of illness); 2 tablets (lopinavir 200 mg/ritonavir 50 mg) were given per oral bid. Interestingly, from the next day of lopinavir/ritonavir administration, β-coronavirus viral load started to decrease and no detectable or little coronavirus titers have been observed since then ( Fig. 2 and Supplementary Fig. 1 ).
Search related documents:
Co phrase search for related documents- hospital day and illness 10 day: 1, 2
- hospital day and viral load: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- illness 10 day and viral load: 1, 2
Co phrase search for related documents, hyperlinks ordered by date